Males with lupus nephritis had higher all-cause mortality and proportion of infection-related death compared to females.

Objective: Examine strategies for early diagnosis/screening, updated treatment guidelines, and treatment and payer considerations to optimize lupus nephritis management and address patient access ...

REPEAT kidney biopsies may play an essential role in managing lupus nephritis, particularly for patients whose disease ...

Early use of mycophenolate mofetil in at-risk patients with SLE reduced the risk of severe flare, potentially delaying lupus nephritis. Early application of mycophenolate mofetil may reduce the ...

Kezar’s decision to terminate the PALIZADE IIb trial comes after it was placed on a clinical hold due to four patient deaths.

Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN ... and potentially prevent or delay progression to ...

Kezar (KZR) is discontinuing development of its drug zetomipzomib for the treatment of lupus nephritis so it can focus on ...

Earlier this month, Kezar Life Sciences announced that the mid-stage test of zetomipzomib in lupus nephritis had been placed ...

She has lupus, and end-stage renal disease, and is looking for a living kidney donor. (Barbara Haddock Taylor/Staff) Wingate, who was diagnosed with lupus nephritis in 2018, said her management of ...

Oct 17 (Reuters) - Kezar Life Sciences (KZR.O), opens new tab said on Thursday it would terminate its mid-stage trial studying its experimental drug in patients with active lupus nephritis and ...

Belimumab added to standard of care (SoC) induction therapy controls disease activity and reduces steroid use in patients with proliferative lupus nephritis (LN), a real-world study shows.